Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure
Public ClinicalTrials.gov record NCT01251406. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Parallel, Placebo-controlled, Double-blind Phase IIa Study of Efficacy and Safety of Recombinant Human Neuregulin-1 (Neucardin) in Subjects With Stable Chronic Heart Failure
Study identification
- NCT ID
- NCT01251406
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Zensun Sci. & Tech. Co., Ltd.
- Industry
- Enrollment
- 67 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- rhNRG-1 Dose 1 Drug
- rhNRG-1 Dose 2 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2011
- Primary completion
- Nov 30, 2012
- Completion
- Feb 28, 2014
- Last update posted
- Feb 9, 2025
2012 – 2014
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California, San Diego | La Jolla | California | 92037 | — |
| Metabolic Clinic and Research Center | Los Angeles | California | 90033 | — |
| USC Cardiovascular Division | Los Angeles | California | 90033 | — |
| Orange County Research Center | Tustin | California | 92780 | — |
| University of Colorado Denver | Denver | Colorado | 80045 | — |
| Clearwater Cardiovascular & Interventional Consultants, MD, PA | Clearwater | Florida | 33756 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | — |
| MedPharmics, LLC. | Kenner | Louisiana | 70065 | — |
| Benchmark Research | Metairie | Louisiana | 70006 | — |
| East Texas Cardiology | Houston | Texas | 77002 | — |
| The Medical Center of Plano | Plano | Texas | 75075 | — |
| Sentara Cardiovascular Research Institute | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01251406, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 9, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01251406 live on ClinicalTrials.gov.